Jean-frédéric Paulsen

Chairman of the Board and Chief Executive Officer, Ferring Ferring Center Sa

Search every verified Jean-frédéric Paulsen interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a June 2020 video interview for the III Stolypin Forum, Frederik Paulsen, Chairman of the Board of Directors of Ferring Pharmaceuticals, discussed the company's operations in Russia and the broader pharmaceutical landscape. Paulsen stated that Ferring is a specialized biotech company focused on reproductive medicine, and that a separate company, Sever, operates two factories in Russia. He noted that Ferring is collaborating with MGIMO University to build new labs for developing technology related to intestinal absorption, with about ten projects planned for development and patenting. Paulsen also mentioned that Ferring is exploring biotechnology work in Kazan and developing nano technologies with its company Nano Pharma. Paulsen identified Russia's declining population as a key issue, stating that while the government has programs to address it, industry and private individuals can also contribute. He said he personally donates a fertility clinic to a Russian city every two years, having given four clinics so far. Regarding tax regulation, Paulsen commented that Russia is not very different from other countries and that taxes are relatively low, though tax authorities conduct thorough audits. He also emphasized the need to internationalize sales of products made in Russia, calling for government assistance to ensure manufacturing standards are accepted internationally.